StockData
Balchem Corp logo

Balchem Corp (BCPC) stock

BCPCNasdaqChemicals & Allied ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 19/3015% above fair value
$173.14+0.79 (+0.46%)

Close on Nov 13, 2026Market cap $5.50BP/E 32.6Yield 0.55%

Balchem ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Balchem's ebitda for the twelve months ending Sep 30, 2026 was $278.40M, up 11.7% year over year. For fiscal 2025 it was $255.02M, up 10.5% from the year before. Over ten years it grew 6.7% a year on average. The highest annual figure on record is $255.02M in fiscal 2025.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025$255.02M+10.5%
FY2024Dec 31, 2024$230.88M+7.8%
FY2023Dec 31, 2023$214.13M+8.7%
FY2022Dec 31, 2022$197.03M+11.7%
FY2021Dec 31, 2021$176.38M+8.6%
FY2020Dec 31, 2020$162.43M+9.4%
FY2019Dec 31, 2019$148.42M-2.2%
FY2018Dec 31, 2018$151.77M+7.4%
FY2017Dec 31, 2017$141.28M+3.1%
FY2016Dec 31, 2016$137.04M+2.3%
FY2015Dec 31, 2015$133.92M+18.9%
FY2014Dec 31, 2014$112.67M+48.1%
FY2013Dec 31, 2013$76.08M+9.6%
FY2012Dec 31, 2012$69.42M+6.0%
FY2011Dec 31, 2011$65.52M+12.3%
FY2010Dec 31, 2010$58.33M+19.6%
FY2009Dec 31, 2009$48.79M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$74.83M+13.1%
Q2 FY2026Jun 30, 2026$71.44M+13.7%
Q1 FY2026Mar 31, 2026$68.12M+9.8%
Q4 FY2025Dec 31, 2025$64.01M+9.7%
Q3 FY2025Sep 30, 2025$66.13M+12.3%
Q2 FY2025Jun 30, 2025$62.85M+7.8%
Q1 FY2025Mar 31, 2025$62.03M+12.1%
Q4 FY2024Dec 31, 2024$58.34M+11.4%
Q3 FY2024Sep 30, 2024$58.90M+2.6%
Q2 FY2024Jun 30, 2024$58.30M+3.6%
Q1 FY2024Mar 31, 2024$55.34M+15.2%
Q4 FY2023Dec 31, 2023$52.39M+11.0%
Q3 FY2023Sep 30, 2023$57.42M+20.3%
Q2 FY2023Jun 30, 2023$56.26M+8.5%
Q1 FY2023Mar 31, 2023$48.05M-4.4%
Q4 FY2022Dec 31, 2022$47.20M+2.4%
Q3 FY2022Sep 30, 2022$47.72M+6.8%
Q2 FY2022Jun 30, 2022$51.85M+21.5%
Q1 FY2022Mar 31, 2022$50.26M+17.1%
Q4 FY2021Dec 31, 2021$46.08M+10.1%
Q3 FY2021Sep 30, 2021$44.67M+6.2%
Q2 FY2021Jun 30, 2021$42.69M+7.6%
Q1 FY2021Mar 31, 2021$42.94M+10.6%
Q4 FY2020Dec 31, 2020$41.86M+16.2%
Q3 FY2020Sep 30, 2020$42.08M+11.4%
Q2 FY2020Jun 30, 2020$39.66M+6.3%
Q1 FY2020Mar 31, 2020$38.83M+4.0%
Q4 FY2019Dec 31, 2019$36.02M-6.3%
Q3 FY2019Sep 30, 2019$37.78M+3.4%
Q2 FY2019Jun 30, 2019$37.30M-2.9%
Q1 FY2019Mar 31, 2019$37.32M-2.7%
Q4 FY2018Dec 31, 2018$38.44M+2.4%
Q3 FY2018Sep 30, 2018$36.56M+7.1%
Q2 FY2018Jun 30, 2018$38.40M+7.9%
Q1 FY2018Mar 31, 2018$38.37M+12.7%
Q4 FY2017Dec 31, 2017$37.52M+3.1%
Q3 FY2017Sep 30, 2017$34.14M–
Q2 FY2017Jun 30, 2017$35.58M–
Q1 FY2017Mar 31, 2017$34.04M–
Q4 FY2016Dec 31, 2016$36.41M–

More Balchem figures

See a number that looks wrong?